Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)

Sinsin Pharmaceutical Revenue

Sinsin Pharmaceutical had revenue of 30.18B KRW in the quarter ending March 31, 2026, with 19.24% growth. This brings the company's revenue in the last twelve months to 118.65B, up 10.90% year-over-year. In the year 2025, Sinsin Pharmaceutical had annual revenue of 113.78B with 6.95% growth.

• Revenue (ttm): 118.65B
• Revenue Growth: +10.90%
• P/S Ratio: 0.56
• Revenue / Employee: 333.28M
• Employees: 356
• Market Cap: 66.45B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	113.78B	7.39B	6.95%
Dec 31, 2024	106.39B	3.80B	3.71%
Dec 31, 2023	102.59B	10.66B	11.60%
Dec 31, 2022	91.93B	17.92B	24.21%
Dec 31, 2021	74.01B	6.88B	10.25%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error